PH16264A - 3,8-dialkylxanthines,their compositions and methods for the treatment of chromic obstructive airway disease and cardiovascular diseases - Google Patents
3,8-dialkylxanthines,their compositions and methods for the treatment of chromic obstructive airway disease and cardiovascular diseasesInfo
- Publication number
- PH16264A PH16264A PH25455A PH25455A PH16264A PH 16264 A PH16264 A PH 16264A PH 25455 A PH25455 A PH 25455A PH 25455 A PH25455 A PH 25455A PH 16264 A PH16264 A PH 16264A
- Authority
- PH
- Philippines
- Prior art keywords
- obstructive airway
- treatment
- airway disease
- sup
- dialkylxanthines
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 230000000414 obstructive effect Effects 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH16264A true PH16264A (en) | 1983-08-23 |
Family
ID=20340763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH25455A PH16264A (en) | 1980-04-18 | 1981-04-01 | 3,8-dialkylxanthines,their compositions and methods for the treatment of chromic obstructive airway disease and cardiovascular diseases |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4546182A (pl) |
| EP (1) | EP0038784B1 (pl) |
| JP (1) | JPS56166191A (pl) |
| AT (1) | ATE10099T1 (pl) |
| AU (1) | AU543122B2 (pl) |
| CA (1) | CA1156229A (pl) |
| DD (1) | DD158400A5 (pl) |
| DE (1) | DE3166893D1 (pl) |
| DK (1) | DK151631B (pl) |
| ES (1) | ES8203088A1 (pl) |
| FI (1) | FI69465C (pl) |
| GR (1) | GR82347B (pl) |
| HU (1) | HU185254B (pl) |
| IE (1) | IE51106B1 (pl) |
| NO (1) | NO811161L (pl) |
| NZ (1) | NZ196829A (pl) |
| PH (1) | PH16264A (pl) |
| PL (1) | PL134762B1 (pl) |
| PT (1) | PT72881B (pl) |
| SE (1) | SE8002910L (pl) |
| ZA (1) | ZA811729B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| US4710503A (en) * | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
| GB8618931D0 (en) * | 1986-08-02 | 1986-09-10 | Euro Celtique Sa | 6-thioxanthines |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| JP2843634B2 (ja) * | 1989-03-06 | 1999-01-06 | 協和醗酵工業株式会社 | キサンチン誘導体 |
| IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
| WO1990012797A1 (en) * | 1989-04-19 | 1990-11-01 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Sulfer-containing xanthine derivatives as adenosin antagonists |
| CA2030112A1 (en) * | 1989-11-24 | 1991-05-25 | Yasuo Ito | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| US5366977A (en) * | 1992-09-29 | 1994-11-22 | The United States Of America, As Represented By The Department Of Health And Human Services | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
| DE4311538C1 (de) * | 1993-04-07 | 1994-10-06 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil |
| WO1994025462A1 (en) * | 1993-05-03 | 1994-11-10 | The United States Of America, Represented By The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| AU2603197A (en) | 1996-04-10 | 1997-10-29 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Use of an a1 adenosine receptor agonist to treat cerebral ischaemia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53890B2 (pl) * | 1972-04-22 | 1978-01-12 | ||
| US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
| CA1077932A (en) * | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
| SE416810C (sv) * | 1977-10-14 | 1982-07-19 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| SE7810946L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
-
1980
- 1980-04-18 SE SE8002910A patent/SE8002910L/xx not_active Application Discontinuation
-
1981
- 1981-03-09 EP EP81850039A patent/EP0038784B1/en not_active Expired
- 1981-03-09 AT AT81850039T patent/ATE10099T1/de not_active IP Right Cessation
- 1981-03-09 DE DE8181850039T patent/DE3166893D1/de not_active Expired
- 1981-03-16 ZA ZA00811729A patent/ZA811729B/xx unknown
- 1981-03-17 CA CA000373230A patent/CA1156229A/en not_active Expired
- 1981-04-01 PH PH25455A patent/PH16264A/en unknown
- 1981-04-03 NO NO811161A patent/NO811161L/no unknown
- 1981-04-08 IE IE769/81A patent/IE51106B1/en unknown
- 1981-04-14 DK DK168281AA patent/DK151631B/da active IP Right Grant
- 1981-04-14 DD DD81229229A patent/DD158400A5/de unknown
- 1981-04-15 AU AU69555/81A patent/AU543122B2/en not_active Ceased
- 1981-04-15 GR GR64702A patent/GR82347B/el unknown
- 1981-04-15 NZ NZ196829A patent/NZ196829A/en unknown
- 1981-04-15 ES ES501400A patent/ES8203088A1/es not_active Expired
- 1981-04-16 PT PT72881A patent/PT72881B/pt unknown
- 1981-04-16 FI FI811212A patent/FI69465C/fi not_active IP Right Cessation
- 1981-04-17 JP JP5724181A patent/JPS56166191A/ja active Pending
- 1981-04-17 PL PL1981230737A patent/PL134762B1/pl unknown
- 1981-04-17 HU HU811020A patent/HU185254B/hu unknown
-
1983
- 1983-08-16 US US06/523,731 patent/US4546182A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES501400A0 (es) | 1982-02-16 |
| GR82347B (pl) | 1984-12-13 |
| PT72881B (en) | 1983-03-29 |
| PL230737A1 (pl) | 1982-03-29 |
| AU6955581A (en) | 1981-10-22 |
| HU185254B (en) | 1984-12-28 |
| DK168281A (da) | 1981-10-19 |
| ZA811729B (en) | 1982-04-28 |
| FI69465C (fi) | 1986-02-10 |
| EP0038784A3 (en) | 1982-01-20 |
| SE8002910L (sv) | 1981-10-19 |
| EP0038784B1 (en) | 1984-10-31 |
| NZ196829A (en) | 1984-12-14 |
| PT72881A (en) | 1981-05-01 |
| EP0038784A2 (en) | 1981-10-28 |
| AU543122B2 (en) | 1985-04-04 |
| IE810796L (en) | 1981-10-18 |
| ES8203088A1 (es) | 1982-02-16 |
| DE3166893D1 (en) | 1984-12-06 |
| DK151631B (da) | 1987-12-21 |
| US4546182A (en) | 1985-10-08 |
| JPS56166191A (en) | 1981-12-21 |
| IE51106B1 (en) | 1986-10-01 |
| PL134762B1 (en) | 1985-09-30 |
| NO811161L (no) | 1981-10-19 |
| CA1156229A (en) | 1983-11-01 |
| FI69465B (fi) | 1985-10-31 |
| FI811212L (fi) | 1981-10-19 |
| ATE10099T1 (de) | 1984-11-15 |
| DD158400A5 (de) | 1983-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH16264A (en) | 3,8-dialkylxanthines,their compositions and methods for the treatment of chromic obstructive airway disease and cardiovascular diseases | |
| EP0011609A3 (en) | Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives | |
| EP0138344A3 (en) | Pyridazinones as beta-adrenoceptor antagonists | |
| EP0150505A3 (en) | 3-indolecarboxamide compounds | |
| HUT37381A (en) | Process for producing new cycloaliphatic compounds of antiandrogenic activity | |
| DE3363550D1 (en) | New nitro aliphatic compounds, process for preparation thereof and use thereof | |
| GB2105992B (en) | Pharmaceutical composition for treatment of cardio-vascular diseases | |
| DE3277971D1 (en) | Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use | |
| ES523719A0 (es) | Procedimiento de preparacion de derivados de fenoxi-3-propa nol-2,en forma de enantiomeros | |
| JPS5780321A (en) | Cardiotonic agent | |
| CA1251463A (en) | SYNTHESIS OF HYDROXYL ANALOGS OR DERIVATIVES OF METHIONINE, AND OF THEIR ESTERS; SYNTHESIS OF 1-ACYLOXY-4-HYDROCARBYLTHIOPROPENE; PRODUCTS OBTAINED | |
| ES8403868A1 (es) | Un procedimiento para producir derivados de prolina. | |
| EP0009326A3 (en) | Pyrrolyl keto and amino acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them | |
| DE3262166D1 (en) | A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition | |
| JPS55145669A (en) | 8,10-diazaprostanoic acid derivative and its preparation | |
| JPS6463520A (en) | Prolactin secretion inhibitor | |
| ES8304924A1 (es) | Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama. | |
| KR830005222A (ko) | 만성 폐쇄성 기도 질병 및 심장혈관 질병치료용의 3,8-디알릴크산틴의 제조방법 및 그 조성물과 치료방법 | |
| ES8502128A1 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
| DE3065093D1 (en) | Therapeutic composition based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation | |
| DE3261643D1 (en) | New peptide, process for preparation thereof and use thereof | |
| KR830001286A (ko) | 만성기도장애증과 심장병치료를 위한 3-알킬 크산틴의 제조방법 | |
| JPS57183798A (en) | N-p-carbamoylphenyl-d-xylopyranosylamine | |
| DE3482857D1 (de) | 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die bekaempfung von herz- und gefaesskrankheiten. |